Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 27;19(1):119.
doi: 10.1186/s12893-019-0586-5.

Challenges and potential solutions to the evaluation, monitoring, and regulation of surgical innovations

Derek J Roberts  1 , David A Zygun  2 , Chad G Ball  3   4 , Andrew W Kirkpatrick  3 , Peter D Faris  5 , Matthew T James  6   7 , Kelly J Mrklas  7   8 , Brenda D Hemmelgarn  6   7 , Braden Manns  6   7 , Henry T Stelfox  6   7   9
Affiliations
Review

Challenges and potential solutions to the evaluation, monitoring, and regulation of surgical innovations

Derek J Roberts et al. BMC Surg. .

Abstract

Background: As it may be argued that many surgical interventions provide obvious patient benefits, formal, staged assessment of the efficacy and safety of surgical procedures has historically been and remains uncommon. The majority of innovative surgical procedures have therefore often been developed based on anatomical and pathophysiological principles in an attempt to better manage clinical problems.

Main body: In this manuscript, we sought to review and contrast the models for pharmaceutical and surgical innovation in North America, including their stages of development and methods of evaluation, monitoring, and regulation. We also aimed to review the present structure of academic surgery, the role of methodological experts and funding in conducting surgical research, and the current system of regulation of innovative surgical procedures. Finally, we highlight the influence that evidence and surgical history, education, training, and culture have on elective and emergency surgical decision-making. The above discussion is used to support the argument that the model used for assessment of innovative pharmaceuticals cannot be applied to that for evaluating surgical innovations. It is also used to support our position that although the evaluation and monitoring of innovative surgical procedures requires a rigorous, fit-for-purpose, and formal system of assessment to protect patient safety and prevent unexpected adverse health outcomes, it will only succeed if it is supported and championed by surgical practice leaders and respects surgical history, education, training, and culture.

Conclusion: We conclude the above debate by providing a recommended approach to the evaluation, monitoring, and regulation of surgical innovations, which we hope may be used as a guide for all stakeholders involved in interpreting and/or conducting future surgical research.

Keywords: Debate; Evidence-based surgery; Pharmaceutical innovation; Surgical innovation; Surgical research.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Barkun JS, Aronson JK, Feldman LS, Maddern GJ, Strasberg SM, Altman DG, Barkun JS, Blazeby JM, Boutron IC, Campbell WB, et al. Evaluation and stages of surgical innovations. Lancet. 2009;374(9695):1089–1096. doi: 10.1016/S0140-6736(09)61083-7. - DOI - PubMed
    1. Roberts Derek J., Ball Chad G., Feliciano David V., Moore Ernest E., Ivatury Rao R., Lucas Charles E., Fabian Timothy C., Zygun David A., Kirkpatrick Andrew W., Stelfox Henry T. History of the Innovation of Damage Control for Management of Trauma Patients. Annals of Surgery. 2017;265(5):1034–1044. doi: 10.1097/SLA.0000000000001803. - DOI - PubMed
    1. Roberts DJ, Bobrovitz N, Zygun DA, Ball CG, Kirkpatrick AW, Faris PD, Stelfox HT. Indications for use of damage control surgery and damage control interventions in civilian trauma patients: a scoping review. J Trauma Acute Care Surg. 2015;78(6):1187–1196. doi: 10.1097/TA.0000000000000647. - DOI - PubMed
    1. Roberts DJ, Bobrovitz N, Zygun DA, Ball CG, Kirkpatrick AW, Faris PD, Brohi K, D'Amours S, Fabian TC, Inaba K, et al. Indications for use of damage control surgery in civilian trauma patients: a content analysis and expert appropriateness rating study. Ann Surg. 2015;263(5):1018–1027. doi: 10.1097/SLA.0000000000001347. - DOI - PubMed
    1. Sweet BV, Schwemm AK, Parsons DM. Review of the processes for FDA oversight of drugs, medical devices, and combination products. J Manag Care Pharm. 2011;17(1):40–50. - PMC - PubMed